
1. hematol oncol clin north am. 2018 apr;32(2):165-175. doi:
10.1016/j.hoc.2017.11.008.

the evolving spectrum epidemiology thalassemia.

weatherall dj(1).

author information: 
(1)university oxford, weatherall institute molecular medicine, john
radcilffe hospital, headington, oxford ox3 9ds, uk. electronic address:
liz.rose@imm.ox.ac.uk.

the thalassemias inherited disorders hemoglobin likely remain
a serious global health problem foreseeable future. currently, are
most frequent tropical belt; assessment true frequency the
likely cost management governments countries require a
form micromapping. recent years, major progress toward
better prevention management thalassemias richer countries; is
likely that, using tools molecular genetics, eventually be
completely curable, although probably long time future.

crown copyright Â© 2017. published elsevier inc. rights reserved.

doi: 10.1016/j.hoc.2017.11.008 
pmid: 29458724  [indexed medline]

